www.latimes.com

www.latimes.com
Share

www.latimes.com

 •  October 9

Pharmaceutical companies have so much power over their customers, it’s practically an abusive relationship. Maybe that’s why consumer advocates are heralding what might otherwise seem like a minor legislative win over Big Pharma. SB 17, which Gov. Jerry Brown signed Monday morning, would not stop drug companies from making a brand new drug costlier...

www.latimes.com

 •  September 22

Seeking to prevent superbug outbreaks, federal health officials said they have approved the first gastrointestinal medical scope with a disposable cap for use in the U.S. The Food and Drug Administration said that the design of the new duodenoscope by Japanese device maker Pentax should make it easier to remove dangerous bacteria that can become...

www.latimes.com

 •  August 31

In a step that heralds a new era in cancer treatment, the U.S. Food and Drug Administration said Wednesday it has approved a form of gene therapy that is highly effective at fighting an aggressive form of leukemia in young patients with no other options. The treatment, to be marketed under the name Kymriah, is neither a pill nor an injection, but a...

www.latimes.com

 •  August 1

After last year’s election, Donald Trump declared his determination “to bring down drug prices.” As president, he’s now reportedly cooking up an executive order aimed at cutting regulations for drug companies, which probably won’t do much to lower prices but should please industry execs. It’s worth asking, though: If Trump really wanted to bring...

www.latimes.com

 •  July 24

A jury ordered giant medical scope maker Olympus Corp. to pay a Seattle hospital $6.6 million in damages tied to a deadly superbug outbreak, and told the hospital to pay $1 million to a deceased patient’s family. But jurors on Monday also handed the Tokyo-based manufacturer a key win, rejecting claims that the company’s flagship medical scope was...

www.latimes.com

 •  May 10

Almost one-third of new drugs approved by U.S. regulators over a decade ended up years later with warnings about unexpected — sometimes life-threatening — side effects or complications, according to a new analysis in the Journal of the American Medical Assn. Researchers looked at potential problems that cropped up during the routine monitoring...

www.latimes.com

 •  April 6

Dr. Scott Gottlieb, President’s Trump’s nominee to head the Food & Drug Administration, has said the FDA displays an “unreasonable hunger for statistical certainty” and a “profound lack of confidence in the ability of doctors to make careful judgments.” In a bid to speed reviews and “change the FDA review culture itself,” Gottlieb proposed in a...

www.latimes.com

 •  April 4

Saying she was alarmed by a new superbug outbreak, a U.S. senator on Tuesday asked Olympus for data showing its redesigned medical scope was safe. In a letter, Sen. Patty Murray (D-Wash.) asked the Japanese device manufacturer for more information about a recent outbreak that sickened five patients in Europe. The patients’ infections, all caused by...

www.latimes.com

 •  March 31

From research on stem cells and DNA sequencing to experiments with fruit flies and surveys of human behavior, projects funded by the National Institutes of Health aim to make Americans healthier. A new analysis finds that NIH-funded research also fuels the kinds of innovations that drive the U.S. economy. Between 1990 and 2012, close to 1 in 10...

www.latimes.com

 •  March 31

Jim Durgeloh, 59, was desperate to avoid surgery. After a career as a construction contractor and hours of leisure time spent on a motorcycle around his Longview, Wash., home, he was facing an operation to replace his left hip. “That’s pretty invasive,” he said, nervous about a surgery that would require being cut open and implanted with an...